A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients with Antibody-Mediated Rejection after Kidney Transplantation
Clinical Trial Grant
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
April 17, 2025
End Date
April 30, 2030
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
April 17, 2025
End Date
April 30, 2030